These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 34845370)
1. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Li X; Hou P; Ma W; Wang X; Wang H; Yu Z; Chang H; Wang T; Jin S; Wang X; Wang W; Zhao Y; Zhao Y; Xu C; Ma X; Gao Y; He H Cell Mol Immunol; 2022 Jan; 19(1):67-78. PubMed ID: 34845370 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide. Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974 [TBL] [Abstract][Full Text] [Related]
3. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. Shi CS; Qi HY; Boularan C; Huang NN; Abu-Asab M; Shelhamer JH; Kehrl JH J Immunol; 2014 Sep; 193(6):3080-9. PubMed ID: 25135833 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. Han L; Zheng Y; Deng J; Nan ML; Xiao Y; Zhuang MW; Zhang J; Wang W; Gao C; Wang PH J Med Virol; 2022 Nov; 94(11):5174-5188. PubMed ID: 35765167 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response. Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279 [TBL] [Abstract][Full Text] [Related]
6. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5. Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255 [TBL] [Abstract][Full Text] [Related]
8. Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy. Wang R; Zhu Y; Ren C; Yang S; Tian S; Chen H; Jin M; Zhou H Autophagy; 2021 Feb; 17(2):496-511. PubMed ID: 32013669 [TBL] [Abstract][Full Text] [Related]
9. DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication. Wang S; Hou P; Pan W; He W; He DC; Wang H; He H J Virol; 2021 Feb; 95(6):. PubMed ID: 33361422 [TBL] [Abstract][Full Text] [Related]
10. RNF34 functions in immunity and selective mitophagy by targeting MAVS for autophagic degradation. He X; Zhu Y; Zhang Y; Geng Y; Gong J; Geng J; Zhang P; Zhang X; Liu N; Peng Y; Wang C; Wang Y; Liu X; Wan L; Gong F; Wei C; Zhong H EMBO J; 2019 Jul; 38(14):e100978. PubMed ID: 31304625 [TBL] [Abstract][Full Text] [Related]
11. Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production. Wang R; Zhu Y; Lin X; Ren C; Zhao J; Wang F; Gao X; Xiao R; Zhao L; Chen H; Jin M; Ma W; Zhou H Autophagy; 2019 Jul; 15(7):1163-1181. PubMed ID: 30741586 [TBL] [Abstract][Full Text] [Related]
12. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174 [TBL] [Abstract][Full Text] [Related]
13. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS. He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways. Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358 [TBL] [Abstract][Full Text] [Related]
15. ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection. Mena EL; Donahue CJ; Vaites LP; Li J; Rona G; O'Leary C; Lignitto L; Miwatani-Minter B; Paulo JA; Dhabaria A; Ueberheide B; Gygi SP; Pagano M; Harper JW; Davey RA; Elledge SJ Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33827988 [TBL] [Abstract][Full Text] [Related]
16. RACK1 degrades MAVS to promote bovine ephemeral fever virus replication via upregulating E3 ubiquitin ligase STUB1. Zhang Y; Hou P; He DC; Wang H; He H Vet Microbiol; 2021 Jun; 257():109096. PubMed ID: 33940459 [TBL] [Abstract][Full Text] [Related]
17. Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus. Zhang LK; Xin QL; Zhu SL; Wan WW; Wang W; Xiao G J Virol; 2016 Nov; 90(22):10259-10270. PubMed ID: 27605671 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response. Fu YZ; Wang SY; Zheng ZQ; Yi Huang ; Li WW; Xu ZS; Wang YY Cell Mol Immunol; 2021 Mar; 18(3):613-620. PubMed ID: 33110251 [TBL] [Abstract][Full Text] [Related]
19. The PB1 protein of influenza A virus inhibits the innate immune response by targeting MAVS for NBR1-mediated selective autophagic degradation. Zeng Y; Xu S; Wei Y; Zhang X; Wang Q; Jia Y; Wang W; Han L; Chen Z; Wang Z; Zhang B; Chen H; Lei CQ; Zhu Q PLoS Pathog; 2021 Feb; 17(2):e1009300. PubMed ID: 33577621 [TBL] [Abstract][Full Text] [Related]